A, M., C, F., L, R., TD, B., L, A., A, E., . . . JI, A. (2020). Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.
Citación estilo ChicagoA, Martín-Nalda, et al. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations. 2020.
Cita MLAA, Martín-Nalda, et al. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations. 2020.
Precaución: Estas citas no son 100% exactas.